EURO-CELTIQUE S.A. Patent applications |
Patent application number | Title | Published |
20160115174 | DIHYDROETORPHINES AND THEIR PREPARATION - The present invention provides a process for the preparation of a compound of formula (VI), or a salt or derivative thereof, | 04-28-2016 |
20160106736 | DIHYDROETORPHINE FOR THE PROVISION OF PAIN RELIEF AND ANAESTHESIA - The present invention provides a method of providing pain relief in a human subject in need thereof comprising administering (R)-dihydroetorphine to said subject, wherein said (R)-dihydroetorphine is administered in a dose of at least 0.01 μg/kg, preferably at least 0.05 μg/kg, and the level of respiratory depression in said subject is 65 or less % relative to the baseline level pre-administration of (R)-dihydroetorphine. | 04-21-2016 |
20150018379 | Intranasal Pharmaceutical Dosage Forms Comprising Naloxone - The present invention relates to an intranasal pharmaceutical dosage form comprising a dosing unit comprising naloxone or a pharmaceutically acceptable salt thereof in an amount of equivalent to ≧0.5 mg naloxone HCl dissolved in an application fluid of a volume of ≦250 μl. Furthermore, the present invention relates to such an intranasal pharmaceutical dosage form for use in the treatment of opioid overdosing and/or at least one symptom thereof. | 01-15-2015 |
20140141063 | HYDROGEL - The invention is related to gel preparations capable of absorbing as well as releasing liquid, and the use of such gel preparations in the treatment of wounds. | 05-22-2014 |
20140094481 | TAMPER RESISTANT DOSAGE FORMS - Tamper resistant controlled release formulations. | 04-03-2014 |
20140066475 | Method For Treating Pruritus - Benzomorphan compounds are found to be useful for treating, ameliorating or preventing pruritus, and in particular pruritus associated with (including induced by) the administration of opioids. Antipruritic activity is believed to be mediated through the dual action of the compounds as mu opioid receptor antagonists and kappa opioid receptor agonists. Pharmaceutical compositions contain therapeutically effective amounts of these useful compounds, optionally in combination with second therapeutic agents, such as opioid or non-opioid analgesics or other compounds. | 03-06-2014 |
20140045878 | MATRIX FOR SUSTAINED, INVARIANT AND INDEPENDENT RELEASE OF ACTIVE COMPOUNDS - The invention concerns a storage stable pharmaceutical formulation comprising preferably two active compounds in a non-swellable diffusion matrix, whereby the compounds are released from the matrix in a sustained, invariant and, if several compounds are present, independent manner and the matrix is determined with respect to its substantial release characteristics by ethylcellulose and at least one fatty alcohol. The invention also concerns methods for producing such pharmaceutical formulations. | 02-13-2014 |
20140031382 | DOSAGE FORM CONTAINING OXYCODONE AND NALOXONE - The present invention concerns a dosage form comprising oxycodone and naloxone which is characterized by specific in vivo parameters such as t | 01-30-2014 |
20130337042 | Use of PVP-Iodine Liposomes for Treatment of Herpes - The invention concerns a method for the production of a pharmaceutical preparation for the treatment of Herpes forms that is characterized in, that the preparation comprises at least one antiseptic compound associated with a particular carrier. | 12-19-2013 |
20130330409 | Dosage Form - The present invention provides a dosage form, particularly a tamper resistant dosage form, comprising; non-stretched melt extruded particulates comprising a drug selected from an opioid agonist, a tranquilizer, a CNS depressant, a CNS stimulant or a sedative hypnotic; and a matrix; wherein said melt extruded particulates are present as a discontinuous phase in said matrix. | 12-12-2013 |
20130197021 | COMBINATION OF ACTIVE LOADED GRANULES WITH ADDITIONAL ACTIVES - The present invention relates to prolonged release pharmaceutical dosage forms, the manufacture thereof as well as their use for administration to human being | 08-01-2013 |
20130178492 | PHARMACEUTICAL COMPOSITIONS COMPRISING HYDROMORPHONE AND NALOXONE - The present invention relates to prolonged release pharmaceutical dosage forms, the manufacture thereof as well as their use for administration to human beings. | 07-11-2013 |
20130122084 | HYDROGEL - The invention is related to gel preparations capable of absorbing as well as releasing liquid, and the use of such gel preparations in the treatment of wounds. | 05-16-2013 |
20120282323 | Dry Liposomal PVP-iodine Compositions - The present invention is directed to a storage stable package of a iodophor containing particulate pharmaceutically acceptable carrier compositions. The invention is particularly directed to a storage stable package of a PVP-iodine liposome compositions. The packaging material is generally plastic, paper or cardboard. | 11-08-2012 |
20120276196 | Pharmaceutical Compositions of a Neuroactive Steroid and Methods of Use Thereof - The present invention relates to pharmaceutical compositions of the neuroactive steroid 3α-hydroxy-3β-methoxymethyl-21-(1′-imidazolyl)-5α-pregnan-20-one or a pharmaceutically-acceptable salt or solvate thereof, with properties desirable for use in treating mood disorders and the like. The pharmaceutical compositions provide sustained therapeutic plasma levels of 3α-hydroxy-3β-methoxymethyl-21-(1′-imidazolyl)-5α-pregnan-20-one. The present invention also relates to methods of treating these disorders by administering the pharmaceutical compositions. | 11-01-2012 |
20120225901 | DOSAGE FORM CONTAINING OXYCODONE AND NALOXONE - The present invention concerns a dosage form comprising oxycodone and naloxone which is characterized by specific in vivo parameters such as t | 09-06-2012 |
20120183612 | MATRIX FOR SUSTAINED, INVARIANT AND INDEPENDENT RELEASE OF ACTIVE COMPOUNDS - The invention concerns a storage stable pharmaceutical formulation comprising preferably two active compounds in a non-swellable diffusion matrix, whereby the compounds are released from the matrix in a sustained, invariant and, if several compounds are present, independent manner and the matrix is determined with respect to its substantial release characteristics by ethylcellulose and at least one fatty alcohol. The invention also concerns methods for producing such pharmaceutical formulations. | 07-19-2012 |
20120135075 | DOSAGE FORM - The present invention provides a dosage form, particularly a tamper resistant dosage form, comprising: melt-extruded particulates comprising a drug; and a matrix; wherein said melt-extruded particulates are present as a discontinuous phase in said matrix. | 05-31-2012 |
20120101118 | TAMPER RESISTANT DOSAGE FORMS - Tamper resistant controlled release formulations. | 04-26-2012 |
20120017900 | Counter - The present invention provices a counter comprising: a first member disposed in at least a partial helical turn about a longitudinal axis of an entity whose movements and/or contents are to be counted, said first member having an indicium or indicia indicative of a count; a second member extending generally in the direction of said longitudinal axis, said second member being operatively disposed in overlapping relationship under and over one or more portions of said at least partial helical turn of said first member; and means to effect relative movement between said first and second members, said movement comprising a relative incremental rotation about said longitudinal axis. | 01-26-2012 |
20120010231 | Dihydroetorphines and Their Preparation - The present invention provides a process for the preparation of a compound of formula (VI), or a salt or derivative thereof, wherein R | 01-12-2012 |
20100087470 | Buprenorphine-Wafer for Drug Substitution Therapy - The present invention relates to oral pharmaceutical dosage forms comprising buprenorphine with the dosage form releasing buprenorphine instantly upon oral, preferably sublingual, application of the dosage form. The present invention also relates to the use of such dosage forms for treating pain in a human or animal or for drug substitution therapy in drug-dependent human subjects. | 04-08-2010 |
20100047337 | PHARMACEUTICAL SPHEROIDS - According to the invention glyceryl monostearate and a polymeric binder are employed as a spheronising aid in the manufacture of pharmaceutical spheroids containing no or substantially no microcrystalline cellulose. The spheroids can contain one or more therapeutically active agent which undergoes no or substantially no degradation when stored under accelerated temperature and humidity conditions. A coating may be applied to the spheroids; when present, the coating is preferably a controlled release coating. | 02-25-2010 |
20090324694 | GASTRORETENTIVE DRUG DELIVERY SYSTEM COMPRISING AN EXTRUDED HYDRATABLE POLYMER - According to the present invention there is provided a pharmaceutical product for retention in the stomach. The product is produced by extrusion. The use of extrusion enables the product to take many useful forms. The product may comprise a sheet of hydratable polymer, the hydrated sheet being of a size which will not pass out of the stomach, for example a shaped sheet or a roll. The product may also comprise a scaled hollow tubular extrudate, for example a tube scaled at both ends. The product may comprise a filled capsule. | 12-31-2009 |
20090169626 | TAMPER RESISTANT DOSAGE FORMS - Tamper resistant controlled release formulations. | 07-02-2009 |
20090118319 | Fused and Spirocycle Compounds and the Use Thereof - The invention relates to fused and spirocycle compounds of Formula (I), or a pharmaceutically acceptable salt, prodrug, or solvate thereof, wherein R | 05-07-2009 |
20090118248 | 3-Alpha-hydroxy 21-n-heteroaryl-pregnane derivatives for modulation of brain excitability and a process for the production thereof - The invention relates to a novel multi step process of making compounds of Formula I: | 05-07-2009 |
20090105249 | 4-phenylsulfonamidopiperidines as calcium channel blockers -
The invention relates to piperidinyl compounds of Formula (I): or a pharmaceutically acceptable salt, prodrug, or solvate thereof, wherein R | 04-23-2009 |
20090022780 | HYDROGEL - The invention is related to gel preparations capable of absorbing as well as releasing liquid, and the use of such gel preparations in the treatment of wounds. | 01-22-2009 |
20080214827 | Synthesis of Cyanoimino-Benzoimidazoles - Disclosed in certain embodiments is a process for synthesizing a compound of formula (V) and salts thereof. | 09-04-2008 |
20080200493 | Use of Oxycodone for Treating Visceral Pain - It is possible to effectively treat moderate to severe visceral pain by administering analgesic medications comprising the opioid oxycodone or pharmaceutically acceptable salts thereof. Visceral pain and especially acute (i.e. non-chronic) visceral pain can be effectively treated by administering oxycodone at a dosage which is lower than the corresponding dosage of other opioids like morphine. | 08-21-2008 |